Back to Newsroom

Great Basin Initiates Clinical Trial for Shiga Toxin-Producing E. coli Molecular Diagnostic Test

SALT LAKE CITY, Feb. 12, 2015 /PRNewswire/ — Great Basin Scientific, Inc. (NASDAQ: GBSN), today announced it has initiated a clinical trial for its Shiga toxin-producing E. coli (STEC) diagnostic test. The Great Basin STEC diagnostic test will also detect serotypeE. coli O157:H7.

Click here to read more